Last reviewed · How we verify
monoclonal antibody 11D10 anti-idiotype — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
monoclonal antibody 11D10 anti-idiotype (monoclonal antibody 11D10 anti-idiotype) — Alliance for Clinical Trials in Oncology.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| monoclonal antibody 11D10 anti-idiotype TARGET | monoclonal antibody 11D10 anti-idiotype | Alliance for Clinical Trials in Oncology | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- monoclonal antibody 11D10 anti-idiotype CI watch — RSS
- monoclonal antibody 11D10 anti-idiotype CI watch — Atom
- monoclonal antibody 11D10 anti-idiotype CI watch — JSON
- monoclonal antibody 11D10 anti-idiotype alone — RSS
Cite this brief
Drug Landscape (2026). monoclonal antibody 11D10 anti-idiotype — Competitive Intelligence Brief. https://druglandscape.com/ci/monoclonal-antibody-11d10-anti-idiotype. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab